ImageneBio, Inc.
IMA
$5.85
-$0.17-2.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | -- | -- | 800.00K | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | -- | -- | 800.00K | 0.00 |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 0.00 | -- | -- | 800.00K | 0.00 |
| SG&A Expenses | 5.23M | 11.04M | 1.71M | 2.76M | 2.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.50M | 26.59M | 7.36M | 6.80M | 6.14M |
| Operating Income | -8.50M | -26.59M | -7.36M | -6.00M | -6.14M |
| Income Before Tax | -7.18M | -24.85M | -7.59M | -6.08M | -4.80M |
| Income Tax Expenses | -276.00K | -74.00K | -- | -- | 13.00K |
| Earnings from Continuing Operations | -6.91M | -24.78M | -7.59M | -6.08M | -4.81M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.91M | -24.78M | -7.59M | -6.08M | -4.81M |
| EBIT | -8.50M | -26.59M | -7.36M | -6.00M | -6.14M |
| EBITDA | -8.11M | -26.59M | -7.36M | -5.99M | -6.12M |
| EPS Basic | -0.67 | -3.01 | -7.60 | -0.02 | -1.46 |
| Normalized Basic EPS | -0.44 | -1.82 | -3.36 | -0.01 | -0.56 |
| EPS Diluted | -0.67 | -3.01 | -7.60 | -0.02 | -1.46 |
| Normalized Diluted EPS | -0.44 | -1.82 | -3.36 | -0.01 | -0.56 |
| Average Basic Shares Outstanding | 10.30M | 8.53M | 1.41M | 462.13M | 5.39M |
| Average Diluted Shares Outstanding | 10.30M | 8.53M | 1.41M | 462.13M | 5.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |